603193.SS SHH
Runben Biotechnology
1W: -1.9%
1M: -2.1%
3M: +5.2%
YTD: -15.3%
1Y: -35.4%
¥20.25 ($3.02)
+0.25 (+1.25%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#12
of 40
Household & Personal Products
Technical Signal Map
3 Bullish
2 Neutral
8 Bearish
603193.SS
$8.2B
Runben Biotechnology
BEARISH
-56
2657.HK
$6.2B
Forest Cabin
BULLISH
+80
003006.SZ
$9.9B
Chongqing Baiya Sanitary Products Co., Ltd.
BULLISH
+78
603983.SS
$12B
Guangdong Marubi Biotechnology Co., Ltd.
BULLISH
+40
300957.SZ
$14B
Yunnan Botanee Bio-Technology Group Co.LTD
NEUTRAL
+9
600315.SS
$12B
Shanghai Jahwa United Co., Ltd.
NEUTRAL
+1
2145.HK
$8.6B
Shanghai Chicmax Cosmetic Co., Ltd.
BEARISH
-58
002511.SZ
$9.0B
C&S Paper Co.,Ltd
BEARISH
-82
6993.HK
$13B
Blue Moon Group Holdings Limited
BEARISH
-87
2367.HK
$26B
Giant Biogene Holding Co., Ltd.
BEARISH
-91
1044.HK
$23B
Hengan International Group Company Limited
BEARISH
-91
1318.HK
$22B
Mao Geping Cosmetics Co., Ltd.
BEARISH
-91
603605.SS
$22B
Proya Cosmetics Co.,Ltd.
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| 603193.SS Runben Biotechnology | $8.2B | 23.0 | 15.6 | 40.7 | 21.9 | 15.9 | 7 | BEARISH | -35.4 |
| 2657.HK Forest Cabin | $6.2B | — | — | — | — | — | — | BULLISH | — |
| 003006.SZ Chongqing Baiya Sanitary Products Co., Ltd. | $9.9B | 50.6 | 14.0 | 20.3 | 4.3 | 3.2 | 6 | BULLISH | -13.6 |
| 603983.SS Guangdong Marubi Biotechnology Co., Ltd. | $12B | 57.3 | 6.4 | 5.9 | 7.0 | -1.0 | 7 | BULLISH | -23.7 |
| 300957.SZ Yunnan Botanee Bio-Technology Group Co.LTD | $14B | 25.0 | 9.0 | 18.5 | 15.3 | 5.2 | 5 | NEUTRAL | -27.4 |
| 600315.SS Shanghai Jahwa United Co., Ltd. | $12B | 31.7 | 5.5 | 3.1 | 8.0 | 13.6 | 9 | NEUTRAL | -17.5 |
| 2145.HK Shanghai Chicmax Cosmetic Co., Ltd. | $8.6B | 10.3 | 68.2 | 49.2 | 2.9 | 78.2 | 7 | BEARISH | -77.1 |
| 002511.SZ C&S Paper Co.,Ltd | $9.0B | 22.4 | 7.1 | 8.9 | 5.6 | 4.7 | 8 | BEARISH | -12.5 |
| 6993.HK Blue Moon Group Holdings Limited | $13B | -136.6 | -7.5 | -16.3 | -6.7 | 7.7 | 4 | BEARISH | -38.3 |
| 2367.HK Giant Biogene Holding Co., Ltd. | $26B | 12.8 | 51.2 | 178.7 | 32.2 | 53.1 | 5 | BEARISH | -60.5 |
| 1044.HK Hengan International Group Company Limited | $23B | 7.8 | 21.8 | 22.5 | 11.3 | -4.6 | 6 | BEARISH | -15.8 |
| 1318.HK Mao Geping Cosmetics Co., Ltd. | $22B | — | — | — | — | — | — | BEARISH | — |
| 603605.SS Proya Cosmetics Co.,Ltd. | $22B | 11.5 | 30.0 | 86.2 | 26.1 | -4.7 | 5 | BEARISH | -33.1 |
| 603193.SS Runben Biotechnology | $8.2B | 23.0 | 15.6 | 40.7 | 21.9 | 15.9 | 7 | BEARISH | -35.4 |
| 2657.HK Forest Cabin | $6.2B | — | — | — | — | — | — | BULLISH | — |
| 003006.SZ Chongqing Baiya Sanitary Products Co., Ltd. | $9.9B | 50.6 | 14.0 | 20.3 | 4.3 | 3.2 | 6 | BULLISH | -13.6 |
| 603983.SS Guangdong Marubi Biotechnology Co., Ltd. | $12B | 57.3 | 6.4 | 5.9 | 7.0 | -1.0 | 7 | BULLISH | -23.7 |
| 300957.SZ Yunnan Botanee Bio-Technology Group Co.LTD | $14B | 25.0 | 9.0 | 18.5 | 15.3 | 5.2 | 5 | NEUTRAL | -27.4 |
| 600315.SS Shanghai Jahwa United Co., Ltd. | $12B | 31.7 | 5.5 | 3.1 | 8.0 | 13.6 | 9 | NEUTRAL | -17.5 |
| 2145.HK Shanghai Chicmax Cosmetic Co., Ltd. | $8.6B | 10.3 | 68.2 | 49.2 | 2.9 | 78.2 | 7 | BEARISH | -77.1 |
| 002511.SZ C&S Paper Co.,Ltd | $9.0B | 22.4 | 7.1 | 8.9 | 5.6 | 4.7 | 8 | BEARISH | -12.5 |
| 6993.HK Blue Moon Group Holdings Limited | $13B | -136.6 | -7.5 | -16.3 | -6.7 | 7.7 | 4 | BEARISH | -38.3 |
| 2367.HK Giant Biogene Holding Co., Ltd. | $26B | 12.8 | 51.2 | 178.7 | 32.2 | 53.1 | 5 | BEARISH | -60.5 |
| 1044.HK Hengan International Group Company Limited | $23B | 7.8 | 21.8 | 22.5 | 11.3 | -4.6 | 6 | BEARISH | -15.8 |
| 1318.HK Mao Geping Cosmetics Co., Ltd. | $22B | — | — | — | — | — | — | BEARISH | — |
| 603605.SS Proya Cosmetics Co.,Ltd. | $22B | 11.5 | 30.0 | 86.2 | 26.1 | -4.7 | 5 | BEARISH | -33.1 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
603193.SS vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F